NCT01030770 - Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage: | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions

Diabetes Complications

Interventions

DRUG

Ranibizumab

Single intravitreal injection of 500 micrograms of ranibizumab (0.05mls).

DRUG

0.9% Sodium Chloride

Single subconjunctival injection of 0.05mls of 0.9% w/v sodium chloride

Trial Locations (2)

Guy's & St. Thomas' Hospital NHS Foundatrion Trust, London

King's College Hospital NHS Foundation Trust, London